Skip to main content
Log in

Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists

  • Research Articles
  • Published:
Experientia Aims and scope Submit manuscript

Abstract

The effects of dopaminergic receptor inhibitors such as thiothixine (D1/D2), fluphenazine (D1/D2), trifluoperazine (D1/D2), pimozide (D2), flupenthixol (D1/D2), (+/−)-SKF 83566 (D1), and spiperone (D2) on splenic natural killer (NK) cell cytotoxic activities were assessed in vitro using mouse spleen lymphocytes or enriched NK cells. Both the activities of the splenic NK cell cytotoxicity and the effector-target cell conjugation were suppressed by thiothixine, fluphenazine, and trifluoperazine at concentrations from 2.64 to 14.78 μM. In addition, the augmentation of the cytolytic activity of NK cells induced by interferon-α or interleukin-2 was antagonized by pretreatment with these neuroleptic compounds. However, neither the splenic NK cell cytotoxicity nor the effector-target cell conjugation were affected by treatment with other neuroleptic compounds such as pimozide, flupenthixol, (+/−)-SKF 83566, and spiperone. Thus, it appears that neuroleptic compounds such as thiothixine, fluphenazine, and trifluoperazine may act through the mechanisms other than a dopaminergic pathway to affect the NK cell-target cell interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Descotes, J., in: Immunotoxicology of Drugs and Chemicals, p. 129. Ed J. Descotes. Elsevier, Amsterdam 1988.

    Google Scholar 

  2. Ferguson, R. M., Schmiditke, J. R., and Simmons, R. L., Nature256 (1975) 744.

    Article  CAS  PubMed  Google Scholar 

  3. Descotes, R., Tedone, R., and Evreuy, J. C. L., J. Neuroimmun.9 (1985) 81.

    Article  CAS  Google Scholar 

  4. Stavitsky, A. B., Dasch, J. R., and Astrachan, L., Cell. Immun.87 (1984) 411.

    Article  CAS  Google Scholar 

  5. Roudebush, R. E., Berry, P. L., Layman, N. K., Butler, L. D., and Bryant, H. U., Int. J. Immunopharmac.13 (1991) 961.

    Article  CAS  Google Scholar 

  6. Descotes, J., and Evreux, J. C. L., Experientia37 (1981) 1004.

    Article  CAS  PubMed  Google Scholar 

  7. Herberman, R. B., and Holden, H. T., Adv. Cancer Res.27 (1978) 305.

    Article  CAS  PubMed  Google Scholar 

  8. Herberman, R. B., in: Nature Cell-mediated Immunity against Tumors, p. 1321. Ed. R. B. Herberman. Academic Press, New York 1980.

    Google Scholar 

  9. Ching, C., and Lopez, C., Infect. Immun.26 (1978) 49.

    Article  Google Scholar 

  10. Ortaldo, J. R., Pathol. Immunopathol. Revs.5 (1986) 203.

    Article  CAS  Google Scholar 

  11. Katz, P., Zaytoun, A. M., and Fauci, A. S., J. Immun.129 (1978) 287.

    Article  Google Scholar 

  12. Locke, S., and Krans, L., in: Biological Mediators of Behavior and Disease: Neoplasia. Ed. S. M. Levy. Elsevier Biomedical, New York 1982.

    Google Scholar 

  13. Hellstrand, K., Hermodsson, S., and Strannegard, O., J. Immun.134 (1985) 4095.

    Article  CAS  PubMed  Google Scholar 

  14. Steele, T. A., and Brahmi, Z., J. Immun.141 (1988) 3164.

    Article  CAS  PubMed  Google Scholar 

  15. Won, S. J., and Lin, M. T., Int. J. Immunopharmac.11 (1989) 451.

    Article  CAS  Google Scholar 

  16. Patel, M. R., and Linna, T. J., Immunology53 (1984) 721.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Saito, T., Welker, R. D., Fukui, H., Herberman, R. B., and Chirigos, M. A., Cell. Immun.90 (1985) 577.

    Article  CAS  Google Scholar 

  18. Leung, K. H., and Ip, M. M., Int. J. Immunopharmac.7 (1985) 857.

    Article  CAS  Google Scholar 

  19. Nitta, T., Yagita, H., Sato, K., and Okumura, K. J., Expl Med.170 (1989) 1757.

    Article  CAS  Google Scholar 

  20. Biron, C. A., Sonnenfeld, G., and Welsh, R. M., J. Leukocyte Biol.35 (1984) 31.

    Article  CAS  PubMed  Google Scholar 

  21. Suzuki, R., Handa, H. I., and Kumagai, K., J. Immun.130 (1983) 981.

    Article  CAS  PubMed  Google Scholar 

  22. Riccardi, C., Vose, M. B., and Herberman, R. B., J. Immun.130 (1983) 228.

    Article  CAS  PubMed  Google Scholar 

  23. Kuribayashi, K., Gillis, S., Kern, D. E., and Henney, C. S., J. Immun.126 (1981) 2321.

    Article  CAS  PubMed  Google Scholar 

  24. Ellis, T. M., McKenzie, R. S., Simms, P. E., Helfrich, B. A., and Fisher, R. E., J. Immun.143 (1989) 4282.

    Article  CAS  PubMed  Google Scholar 

  25. Ortaldo, J. R., and Herberman, R. B., in: Immunobiology of Natural Killer Cells, vol. 2. p. 145. Eds E. Lotzova, R. B. Herberman. CRC Press, Boca Raton, FL 1986.

    Google Scholar 

  26. Djeu, J. Y., Stocks, N., Varesio, L., Holden, H. T., and Herberman, R. B., Cell. Immun.58 (1981) 49.

    Article  CAS  Google Scholar 

  27. Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H., and Ritz, J., J. Immun.154 (1990) 3184.

    Google Scholar 

  28. Zarcone, D., Prasthofer, E. F., Malavasi, F., Pistoia, V., LoBuglio, A. F., and Grossi, C. E., Blood69 (1987) 1725.

    Article  CAS  PubMed  Google Scholar 

  29. Manyak, C. L., Norton, G. P., Lobe, C. G., Bleackley, R. C., Gershenfeld, H. K., Weissman, I. L., Kumar, V., Signal, N. H., and Koo, G. C., J. Immun.142 (1989) 3707.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Won, S.J., Chuang, Y.C., Huang, W.T. et al. Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists. Experientia 51, 343–348 (1995). https://doi.org/10.1007/BF01928892

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01928892

Key words

Navigation